相关实验视频
Updated: Apr 13, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.6K
调整用于解释血p-tau217水平的值
Jehyun Ahn1, Eun Hye Lee2,3, Heejin Yoo1
1Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Gangnam-gu, Korea (the Republic of).
Journal of neurology, neurosurgery, and psychiatry
|May 24, 2025
概括
血化陶 (p-tau) 217项测试显示,在受损个体中,对阿尔茨海默氏病 (AD) 诊断的准确性很高. 针对没有障碍的个体,特别是65岁以下的个体,需要量身定制的切断线,以实现最佳的AD检测.
科学领域:
- 神经学 神经学
- 生物标志物发现发现
- 阿尔茨海默氏症疾病的诊断方法
背景情况:
- 化化 (p-tau) 217是阿尔茨海默病 (AD) 的一个有前途的血液检测.
- 它在不同患者子组的诊断性能需要进一步调查.
- 这项研究评估了p-tau217在各种认知和人口群体中的效用.
研究的目的:
- 用双切线方法评估血p-tau217的诊断准确性.
- 分析各个子组的表现,包括认知状态,年龄,性别,BMI和APOE ε4状态.
- 探索针对特定人群量身定制的切断策略.
主要方法:
- 在认知不受损 (CU) 和认知受损 (CI) 个体中分析了血p-tau217水平.
- 使用双切线来将参与者分为粉样蛋白阴性,中间和粉样蛋白阳性组.
- 在子组中评估诊断性能指标 (灵敏度,特异性,PPV,NPV).
主要成果:
- 最佳的p-tau217截止值在CU和CI组之间有所不同.
- 在CI组中观察到所有子组的高诊断准确性 (灵敏度和特异性≥90%).
- 在CU组中,替代切割值提高了对85.0%的灵敏度,并在65岁以下的个体中保持了95.7%的特异性.
结论:
- 血p-tau217在认知障碍患者中显示出强大的诊断准确性.
- 定制的切断值对于优化p-tau217在没有认知障碍的人群中的使用至关重要.
- 这些发现支持将血p-tau217纳入AD诊断和风险分层的临床工作流程.
相关概念视频
Kendall's Tau Test
1.3K
Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1 indicates...
A τ value of +1 indicates...
1.3K
Therapeutic Drug Monitoring: Drug Analysis Methods
319
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
319

